Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: Impact of N-acetylcysteine

Kidney International

Volumn 68, Issue 5, 2005, Pages 2250-2255

  Briguori, Carlo ^a   Colombo, Antonio ^b   Airoldi, Flavio ^b   Morici, Nuccia ^b   Sangiorgi, Giuseppe Massimo ^b   Violante, Anna ^b   Focaccio, Amelia ^b   Montorfano, Matteo ^b   Carlino, Mauro ^b   Condorelli, Gianluigi ^b   Ricciardelli, Bruno ^b  

^a Clinica Mediterranea   (Italy)

^b NONE

Author keywords

Complications; Contrast media; Kidney; Prevention

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; CREATININE; IOBITRIDOL; IODIXANOL; SODIUM CHLORIDE; XENETIN;

ADULT; AGED; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OSMOLALITY; PATIENT REFERRAL; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT;

ACETYLCYSTEINE; AGED; CONTRAST MEDIA; FEMALE; FLUID THERAPY; HUMANS; IOHEXOL; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; TRIIODOBENZOIC ACIDS;

EID: 24644523235     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00683.x     Document Type: Conference Paper

References (34)

1. PARFREY PS, GRIFFITHS SM, BARRETT BJ, et al: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143-149, 1989
2. CHERTOW GM, CHRISTIANSEN CL, CLEARY DP: Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 155:1505-1511, 1995
3. GRUBERG L, MEHRAN R, DANGAS G, et al: Acute renal failure requiring dialysis after percutaneous coronary interventions. Cathet Cardiovasc Intervent 52:409-416, 2001
4. MCCULLOUGH PA, WOLYN R, ROCHER LL, et al: Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 103:368-375, 1997
5. SOLOMON R, WERNER C, MANN D, et al: Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420, 1994
6. SCHWAB SJ, HLATKY MA, PIEPER KS, et al: Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320:149-53, 1989
7. BARRETT BJ, CARLISLE EJ: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993
8. STEINBERG EP, MOORE RD, POWE NR, et al: Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl Med J 326:425-430, 1992
9. CIGARROA RG, LANGE RA, WILLIAMS RH, HILLIS LD: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649-652, 1989
10. TEPEL M, VAN DER GIET M, SCHWARZEELD C, et al: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184, 2000
11. SHYU KG, CHENG JJ, KUAN P: Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40:1383-1388, 2002
12. KAY J, CHOW WH, CHAN TM, et al: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 289:553-558, 2003
13. BRIGUORI C, COLOMBO A, VIOLANTE A, et al: Standard versus double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25:206-211, 2004
14. BRIGUORI C, COLOMBO A, AIROLDI F, et al: N-Acetylcysteine versus fenoldopam mesylate to prevent contrast-agent associated nephrotoxicity. J Am Coll Cardiol 44:762-765, 2004
15. BIRCK R, KRZOSSOK S, MARKOWETZ F, et al: Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 362:598-603, 2003
16. DIMARI J, MEGYESI J, UDVARHELYI N, et al: N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 272:F292-F298, 1997
17. TARIQ M, MORAIS C, SOBKI A, et al: N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 14:923-929, 1999
18. ASPELIN P, AUBRY P, FRANSSON SG, et al: Nephrotoxic effects in high-risk patients undergoing angioplasty. N Engl J Med 348:491-499, 2003
19. ASPELIN P, AUBRY P, FRANSSON SG, et al: Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy. Am Heart J 149:298-303, 2005
20. NATIONAL KIDNEY FOUNDATION: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39(Suppl 1):S1-237, 2002
21. MEHRAN R, AYMONG ED, NIKOLSKY E, et al: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 44:1393-1399, 2004
22. SUTTON AGC, FINN P, GRECH ED, et al: Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 141:677-683, 2001
23. REED JR, WILLIAMS RH, LUKE RG: The renal hemodynamic response to diatrizoate in normal and diabetic rates. Invest Radiol 18:536-540, 1983
24. HIZOH I, STREATER J, SCHISK CS, et al: Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: Role of hypertonicity. Nephrol Dial Transplant 13:911-918, 1998
25. HARDICK K, KATHOLI RE, RAMKUMAR V, DEITRICK C: Proximal table cell response to radiographic contrast media. Am J Physiol Renal Physiol 280:F61-F70, 2001
26. JAKOBSEN JA, LUNDBY B, KRISTOFFERSEN DT, et al: Evaluation of renal function with delayed CT after injection of non-ionic monomeric and dimeric contrast media in healthy volunteers. Radiology 182:419-424, 1992
27. MURAKAMI R, TAJIMA H, KUMAZAKI T, YAMAMOTO K: Effect of iodixanol on renal function immediately after abdominal angiography. Acta Radiologica 19:368-371, 1998
28. LANCELOT E, IDEE JM, VAZIN V, COROT C: Influence of viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: A potential cause of nephrotoxicity. J Appl Toxicol 19:341-346, 1999
29. STACUL F, COVA M, ASSANTE M, et al: Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency. Br J Radiol 71:918-922, 1998
30. CARRARO M, MALALAN F, ANTONIONE R, et al: Effects of dimeric versus monomeric nonionic contrast media on renal function in patients with mild to moderate renal insufficiency: A double blind randomized clinical trial. Eur Radiol 8:144-147, 1998
31. CHALMERS N, JACKSON RW: Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72:701-703, 1999
32. JAKOBSEN JA, BERG KJ, KIAERSGAARD P, et al: Angiography with nonionic X-ray contrast media in severe chronic renal failure: Renal function and contrast retention. Nephron 73:549-556, 1996
33. RUDNICK MR, GOLDFARB S, WEXLER L, et al: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254-261, 1995
34. COTGREASE I, MOLDEUS P, SCHUPPE I: The metabolism of N-acetylcysteine by human endothelial cells. Biochem Pharmacol 42:13-16, 1991